When One Problem Is Never Just One Problem

For anyone living with both an addiction and a mental health condition, dual disorder treatment is rarely straightforward. These two issues do not sit neatly side by side. They feed into each other, shape each other, and in many cases, one simply cannot be resolved without addressing the other. Yet for decades, healthcare systems have treated them in separate rooms, with separate teams, following separate plans.

A major international consensus published in the Journal of Clinical Medicine in early 2026 makes the case, backed by rigorous scientific review, that this siloed approach is not good enough. The World Association on Dual Disorders (WADD) and the Spanish Society of Dual Disorders (SEPD) produced the findings together. Their conclusion is clear: integrated psychological treatment that addresses both conditions at the same time, under the same roof, with the same team, produces better outcomes for patients.

What Is a Dual Disorder?

A dual disorder, sometimes called a co-occurring or concurrent disorder, refers to the simultaneous presence of a substance use disorder and at least one other mental health condition. This might be alcohol dependence alongside depression, cannabis use alongside anxiety, or opioid misuse alongside post-traumatic stress disorder (PTSD).

The relationship between the two is rarely one-directional. Some people begin using substances to cope with existing psychological distress. Prolonged substance use can also trigger or worsen mental health symptoms. In both cases, treating only one disorder leaves the other untouched, and that tends to end in relapse.

The consensus also notes that the definition of dual disorder now extends to behavioural addictions, such as gambling disorder, which share clinical and neurobiological features with substance-based addictions.

A Crisis Hidden in Plain Sight

The scale of the problem is striking. Studies cited in the consensus estimate that more than 90% of adults with a dual disorder do not receive specific, coordinated treatment for both conditions. That is not a marginal gap. That is a systemic failure.

“This lack of a comprehensive approach can hinder recovery and increase the risk of relapse,” said Professor Ana Adan, co-author of the consensus and a member of the Department of Clinical Psychology and Psychobiology at the University of Barcelona. “The separation between services or treatments does not always reflect the clinical reality of these individuals.”

In practice, a patient might receive substance misuse support from one service while their anxiety or personality disorder goes unaddressed, if it gets addressed at all. Neither condition then improves as much as it should.

Integrated Dual Disorder Treatment: What the Evidence Says

Researchers reviewed psychological therapies across a wide range of dual disorder combinations. These included neurodevelopmental disorders such as ADHD, anxiety disorders, PTSD, somatic symptom disorders, eating disorders, and personality disorders.

Several consistent patterns emerged.

Cognitive Behavioural Therapy (CBT) came out as the most widely supported first-line treatment across almost every dual disorder category. For anxiety disorders alongside substance use, CBT proved more cost-effective than medication, particularly for patients with limited prior exposure to benzodiazepines. Its effectiveness extended to eating disorders, particularly bulimia. In ADHD, combining CBT with pharmacological treatment significantly improved both ADHD and substance use symptoms.

Trauma-focused therapies proved particularly important for patients with dual PTSD. Cognitive Processing Therapy (CPT) and Prolonged Exposure therapy (PEx) both demonstrated strong results. CPT was associated with higher treatment completion rates. EMDR combined with schema therapy also showed promising early results.

For borderline personality disorder (BPD) alongside substance use, Dialectical Behaviour Therapy (DBT) emerged as the preferred approach, particularly for patients with frequent suicidal ideation. Dynamic deconstructive psychotherapy and dual-focus schema therapy were also highlighted as promising options.

For antisocial personality disorder (ASPD), CBT, contingency management, and a brief psychoeducational approach called Impulsive Lifestyle Counselling all showed measurable reductions in substance use and improvements in treatment adherence.

In dual ADHD, the consensus recommends a multicomponent model: psychoeducation in the first phase, followed by individual or group CBT with peer and family support in the second. Combined pharmacotherapy and psychotherapy outperforms medication alone.

Why Integrated Psychological Treatment Changes Outcomes

The most consistent message running through the consensus is straightforward: one team, one plan, one shared understanding of how the two conditions relate to each other works better than splitting care across services.

“When addiction and mental health disorders are treated separately, the risk of repeated relapses is higher,” said researcher Ana Benito, first author of the consensus articles and a member of the Spanish Society of Dual Disorders. “An integrated approach helps break this cycle, reduces relapse and improves treatment adherence.”

The consensus draws a careful distinction between integrated and parallel treatment. Parallel treatment involves two different teams working independently at the same time. Integrated dual disorder treatment means one team managing a coherent, shared plan.

Where full integration is not possible, for example in eating disorders, the consensus recommends treating the substance use disorder first to stabilise the patient. Clinicians should prioritise medical and weight stabilisation from the outset before moving to the eating disorder itself.

Where the Gaps Still Are

For all its clarity on what works, the consensus is equally frank about what remains unknown. Dual social anxiety, panic disorder, generalised anxiety disorder, somatic symptom disorders, and eating disorders beyond bulimia remain significantly under-researched in the dual disorder context.

Key limitations include small sample sizes, a lack of randomised controlled trials, inconsistent definitions of standard treatment, and the routine exclusion of dual disorder patients from single-condition studies. The consensus sets out 19 specific recommendations for future research to address these gaps.

The authors call for standardised outcome measures, long-term safety data, attention to demographic variables including age, gender, culture and geography, and evaluation of treatments in resource-limited settings outside specialist clinics.

Why This Matters Beyond the Clinic

Substance use and mental health conditions affect millions of people across the UK and globally. They cut across age groups, backgrounds and circumstances. The evidence reviewed here makes one thing clear: recovery is most achievable when both conditions are taken seriously, treated together and followed up properly over time.

One finding stands out beyond any specific therapy. The quality of the relationship between a patient and their clinician, what researchers call the therapeutic alliance, was identified as the single strongest predictor of treatment outcome in personality disorder cases. No protocol replaces that.

The consensus used a combination of the nominal group technique and the Delphi method to reach agreement among leading experts across multiple countries. It serves as both a clinical reference and a signal to health systems: splitting addiction and mental health into separate tracks produces incomplete results for the people who need complete care.

Reference: Benito A. et al., WADD-SEPD Consensus on Psychological Treatment of Dual Disorders II. Journal of Clinical Medicine, 2026. DOI: 10.3390/jcm15031105

Source: dbrecoveryresources